Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Bevacizumab for the Treatment of Patients With Low Vision Due to Neovascular Age-related Macular Degeneration

NCT01327222 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT01327222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01327222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Bevacizumab for the Treatment of Patients With Low Vision Due to Neovascular Age-related Macular Degeneration
Lead sponsor
IRCCS San Raffaele
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2011
Completion date
February 28, 2011
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration